新诊断的低性周期性是由COVID-19引发的
Kelly Schulte1, Maxwell Sheedy2, Kavanya Feustel3
1Internal Medicine, Sky Ridge Medical Center, Lone Tree, USA.
Cureus
|November 30, 2023
概括
一种罕见的遗传疾病 - - 低血压周期性 (HypoPP) 可能是由COVID-19引发的. 这个案例突出了一个年轻的男性,由于低的严重肌肉衰弱,与COVID-19感染有关.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 遗传学 遗传学 是一个
背景情况:
- 低性周期性 (HypoPP) 是一种罕见的遗传疾病,由于含量低,会导致偶发性肌肉衰弱.
- 已知病毒感染是HypoPP的触发因素,但COVID-19的相关性很少.
研究的目的:
- 报告一个由COVID-19引发的HypoPP独特病例.
- 强调在患有肌肉衰弱和同时患有COVID-19的患者中考虑HypoPP的重要性.
主要方法:
- 一个临床案例展示了一个23岁的男性突然出现的软弱.
- 实验室调查显示严重的低血 (1.1 mmol/L) 和阳性COVID-19测试.
- 临床检查包括家族病史,导致诊断为HypoPP.
主要成果:
- 患者出现了严重的肌肉衰弱和严重的低血清症.
- 补充可以快速缓解症状.
- 诊断的HypoKalemic周期性被证实,由家族病史支持.
结论:
- COVID-19可以导致低卡利米周期性,即使在以前健康的个体中.
- 临床医生应考虑在COVID-19感染期间出现肌肉虚弱的患者中使用HypoPP.
- 及时识别和治疗低血清症对于预防严重并发症至关重要.
相关概念视频
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics
582
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
582
Myasthenia Gravis: Diagnostic Tests
890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890
Depolarizing Blockers: Pharmocokinetics
328
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
328
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375


